The literature concerning muscle Glycogenoses reflects a worldwide interest which has been greatly intensified, mainly over the last ten years. To a large extent, this renewed interest is due to recent advances in diagnosing and treating the Lysosomal disease named Glycogenosis II or Pompe disease (GSD II). The new therapeutic approaches must induce us to make a great effort in order to better diagnose, treat and follow correctly the patients with Pompe disease. This book is a comprehensive text which covers all of the aspects regarding this disease, from pathogenic to clinical and therapeutic features. © 2013 by Nova Science Publishers, Inc. All rights reserved
Pompe disease (acid alpha-glucosidase deficiency, OMIM 232300) is a rare lysosomal storage disorder ...
Glycogen storage disease type Ⅱ (GSD Ⅱ), which is also called Pompe disease, is an autosomal recessi...
Introduction: Pompe disease (PD) is a rare metabolic disorder caused by a partial or complete defici...
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement...
Glycogen storage diseases (GSDs) are a group of rare, monogenic disorders that share a defect in the...
<p>The paper gives the data available in the literature, which reflect the manifestations, diagnosis...
Pompe's disease, glycogen-storage disease type II, and acid maltase deficiency are alternative names...
Juan Francisco Cabello,1 Deborah Marsden21Genetics and Metabolic Disease Laboratory, Nutrition and F...
The glycogen storage disease type II (GSD-II), or Pompe disease, is due to the deficit of lysosomal ...
Glycogen storage disease type II (GSDII, Pompe disease) is a rare metabolic disorder caused by a def...
Pompe disease (PD) is a metabolic myopathy caused by the deficiency of the lysosomal hydrolase acid ...
Ilka Schneider, Stephan Zierz Department of Neurology, Martin Luther University Halle-Wittenberg, Ha...
markdownabstract__Abstract__ Pompe disease, also known as glycogen storage disorder type II and a...
Pompe disease (PD) is an autosomal recessive disease caused by partial or complete deficiency of the...
Glycogen storage disease type II- also called Pompe disease or acid maltase deficiency- is an autoso...
Pompe disease (acid alpha-glucosidase deficiency, OMIM 232300) is a rare lysosomal storage disorder ...
Glycogen storage disease type Ⅱ (GSD Ⅱ), which is also called Pompe disease, is an autosomal recessi...
Introduction: Pompe disease (PD) is a rare metabolic disorder caused by a partial or complete defici...
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement...
Glycogen storage diseases (GSDs) are a group of rare, monogenic disorders that share a defect in the...
<p>The paper gives the data available in the literature, which reflect the manifestations, diagnosis...
Pompe's disease, glycogen-storage disease type II, and acid maltase deficiency are alternative names...
Juan Francisco Cabello,1 Deborah Marsden21Genetics and Metabolic Disease Laboratory, Nutrition and F...
The glycogen storage disease type II (GSD-II), or Pompe disease, is due to the deficit of lysosomal ...
Glycogen storage disease type II (GSDII, Pompe disease) is a rare metabolic disorder caused by a def...
Pompe disease (PD) is a metabolic myopathy caused by the deficiency of the lysosomal hydrolase acid ...
Ilka Schneider, Stephan Zierz Department of Neurology, Martin Luther University Halle-Wittenberg, Ha...
markdownabstract__Abstract__ Pompe disease, also known as glycogen storage disorder type II and a...
Pompe disease (PD) is an autosomal recessive disease caused by partial or complete deficiency of the...
Glycogen storage disease type II- also called Pompe disease or acid maltase deficiency- is an autoso...
Pompe disease (acid alpha-glucosidase deficiency, OMIM 232300) is a rare lysosomal storage disorder ...
Glycogen storage disease type Ⅱ (GSD Ⅱ), which is also called Pompe disease, is an autosomal recessi...
Introduction: Pompe disease (PD) is a rare metabolic disorder caused by a partial or complete defici...